Interestingly, in this cohort of patients, the number of tumor-infiltrating CD8+, CD68+, and the CD68+/CD8 + ratio did not differ in invasive and non-invasive tumors and with the overall outcome of the disease. The gene discussed is CD8A; the disease is neoplasm.